Skip to Content
Merck
  • Genomic and transcriptomic studies of an RDX (hexahydro-1,3,5-trinitro-1,3,5-triazine)-degrading actinobacterium.

Genomic and transcriptomic studies of an RDX (hexahydro-1,3,5-trinitro-1,3,5-triazine)-degrading actinobacterium.

Applied and environmental microbiology (2012-08-28)
Hao-Ping Chen, Song-Hua Zhu, Israël Casabon, Steven J Hallam, Fiona H Crocker, William W Mohn, Karl J Indest, Lindsay D Eltis
PMID22923396
ABSTRACT

Whole-genome sequencing, transcriptomic analyses, and metabolic reconstruction were used to investigate Gordonia sp. strain KTR9's ability to catabolize a range of compounds, including explosives and steroids. Aspects of this mycolic acid-containing actinobacterium's catabolic potential were experimentally verified and compared with those of rhodococci and mycobacteria.